As of 2024-09-18, the Relative Valuation of Lexicon Pharmaceuticals Inc (LXRX) is (17.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.62 USD, the upside of Lexicon Pharmaceuticals Inc based on Relative Valuation is -1195.6%.
The range of the Relative Valuation is (16.32) - (12.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 29.2x - 57.1x | 43.2x |
| Forward P/E multiples | 18.2x - 22.5x | 20.4x |
| Fair Price | (16.32) - (12.58) | (17.75) |
| Upside | -1107.6% - -876.4% | -1195.6% |
| Date | P/E |
| 2024-09-18 | -2.93 |
| 2024-09-17 | -2.90 |
| 2024-09-16 | -2.92 |
| 2024-09-13 | -3.04 |
| 2024-09-12 | -2.99 |
| 2024-09-11 | -3.02 |
| 2024-09-10 | -2.99 |
| 2024-09-09 | -2.99 |
| 2024-09-06 | -2.88 |
| 2024-09-05 | -2.90 |
| 2024-09-04 | -2.92 |
| 2024-09-03 | -2.88 |
| 2024-08-30 | -3.09 |
| 2024-08-29 | -3.22 |
| 2024-08-28 | -3.08 |
| 2024-08-27 | -3.08 |
| 2024-08-26 | -3.17 |
| 2024-08-23 | -3.27 |
| 2024-08-22 | -3.27 |
| 2024-08-21 | -3.42 |
| 2024-08-20 | -3.01 |
| 2024-08-19 | -3.02 |
| 2024-08-16 | -2.97 |
| 2024-08-15 | -2.93 |
| 2024-08-14 | -2.93 |
| 2024-08-13 | -3.09 |
| 2024-08-12 | -2.84 |
| 2024-08-09 | -2.86 |
| 2024-08-08 | -3.01 |
| 2024-08-07 | -2.79 |
| 2024-08-06 | -2.93 |
| 2024-08-05 | -2.71 |
| 2024-08-02 | -3.03 |
| 2024-08-01 | -3.61 |
| 2024-07-31 | -4.02 |
| 2024-07-30 | -3.99 |
| 2024-07-29 | -4.11 |
| 2024-07-26 | -4.28 |
| 2024-07-25 | -4.17 |
| 2024-07-24 | -3.88 |
| 2024-07-23 | -3.97 |
| 2024-07-22 | -3.77 |
| 2024-07-19 | -3.56 |
| 2024-07-18 | -3.74 |
| 2024-07-17 | -3.81 |
| 2024-07-16 | -3.99 |
| 2024-07-15 | -3.79 |
| 2024-07-12 | -3.54 |
| 2024-07-11 | -3.33 |
| 2024-07-10 | -2.92 |